Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast CancerRobin Hallett, John A. Hassell|PLoS ONE|2012Cited by 93
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenograftsWilliam D. Gwynne, John A. Hassell|Oncotarget|2017Cited by 52
Antagonists of the serotonin receptor 5A target human breast tumor initiating cellsWilliam D. Gwynne, John A. Hassell|BMC Cancer|2020Cited by 20